Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics
Adam J. Nelson, Lisa A. Kaltenbach, Darren K. McGuire, Monica Levya, Hussein R. Al‐Khalidi, Laura Webb, Renato D. Lópes, Rodica Pop‐Busui, Matthew A. Cavender, Vanita R. Aroda, Melissa Magwire, Caroline R. Richardson, Ildiko Lingvay, Julienne K. Kirk, Ambarish Pandey, Tanya Gaynor, Jonathan Pak, Alana Washington, Çağrı Şenyücel, Jennifer B. Green, Christopher B. Granger, Neha J. Pagidipati
Topics & Concepts
MedicineDiscontinuationAtherosclerotic cardiovascular diseaseType 2 diabetesDiabetes mellitusDiseaseInternal medicineCardiologyIntensive care medicineEndocrinologyDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesHyperglycemia and glycemic control in critically ill and hospitalized patients